|
US2859239A
(en)
*
|
1956-08-17 |
1958-11-04 |
Dow Chemical Co |
Acrylic acid compounds
|
|
CH549339A
(de)
|
1971-05-12 |
1974-05-31 |
Ciba Geigy Ag |
Herbizides mittel.
|
|
US5763647A
(en)
*
|
1990-03-30 |
1998-06-09 |
Shionogi & Co., Ltd. |
Preparation of optically active 1,4-bridged-cyclohexane carboxylic acid derivatives
|
|
CA2072270A1
(en)
*
|
1991-06-26 |
1992-12-27 |
Joseph V. Koleske |
Production of unsaturated cycloaliphatic esters and derivatives thereof
|
|
JP4135318B2
(ja)
|
1997-12-15 |
2008-08-20 |
アステラス製薬株式会社 |
新規なピリミジン−５−カルボキサミド誘導体
|
|
AU5438299A
(en)
|
1998-08-29 |
2000-03-21 |
Astrazeneca Ab |
Pyrimidine compounds
|
|
ATE288420T1
(de)
|
1999-06-09 |
2005-02-15 |
Yamanouchi Pharma Co Ltd |
Neuartige heterocyclische carboxamid-derivate
|
|
WO2000076980A1
(en)
|
1999-06-10 |
2000-12-21 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
|
|
EP1206265B1
(en)
|
1999-06-30 |
2003-11-12 |
Merck & Co., Inc. |
Src kinase inhibitor compounds
|
|
CZ2002534A3
(cs)
|
1999-08-13 |
2002-07-17 |
Vertex Pharmaceuticals Incorporated |
Inhibitory protein-kináz, farmaceutické prostředky, které je obsahují, a jejich pouľití
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
JPWO2003082855A1
(ja)
|
2002-03-28 |
2005-08-04 |
協和醗酵工業株式会社 |
抗炎症剤
|
|
AU2003244098A1
(en)
|
2002-06-28 |
2004-01-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Diaminopyrimidinecarboxa mide derivative
|
|
CN103169708B
(zh)
|
2002-07-29 |
2018-02-02 |
里格尔药品股份有限公司 |
用2,4‑嘧啶二胺化合物治疗或者预防自体免疫性疾病的方法
|
|
JPWO2004054617A1
(ja)
|
2002-12-13 |
2006-04-20 |
協和醗酵工業株式会社 |
中枢疾患の予防および／または治療剤
|
|
CN1315777C
(zh)
*
|
2003-01-16 |
2007-05-16 |
东丽泛应化学(股) |
旋光二酰基酒石酸的回收方法
|
|
WO2004065378A1
(en)
|
2003-01-17 |
2004-08-05 |
Warner-Lambert Company Llc |
2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation
|
|
EP1590334B1
(en)
|
2003-01-30 |
2009-08-19 |
Boehringer Ingelheim Pharmaceuticals Inc. |
2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
|
|
JP4607879B2
(ja)
|
2003-08-15 |
2011-01-05 |
ノバルティス アーゲー |
新生物疾患、炎症および免疫障害の処置に有用な２，４−ピリミジンジアミン
|
|
MXPA06003207A
(es)
|
2003-09-24 |
2006-06-23 |
Wyeth Corp |
5-arilpirimidinas como agentes anti-cancer.
|
|
US7956060B2
(en)
|
2004-03-30 |
2011-06-07 |
Kyowa Hakko Kirin Co., Ltd. |
Pyrimidine derivative compound
|
|
EP1765791A1
(en)
|
2004-07-08 |
2007-03-28 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Pyrimidine derivatives useful as inhibitors of pkc-theta
|
|
CA2579007A1
(en)
|
2004-09-10 |
2006-03-16 |
Altana Pharma Ag |
Ciclesonide and syk inhibitor combination and methods of use thereof
|
|
WO2006027378A1
(en)
|
2004-09-10 |
2006-03-16 |
Altana Pharma Ag |
Roflumilast and syk inhibitor combination and methods of use thereof
|
|
JP2006124387A
(ja)
|
2004-09-30 |
2006-05-18 |
Taisho Pharmaceut Co Ltd |
新規なキノリン、テトラヒドロキナゾリン、及びピリミジン誘導体と、これらを使用することに関連した治療方法
|
|
ES2380631T3
(es)
|
2004-09-30 |
2012-05-17 |
Tibotec Pharmaceuticals |
Pirimidinas sustituidas en posición 5 inhibidoras de VIH
|
|
WO2006091737A1
(en)
|
2005-02-24 |
2006-08-31 |
Kemia, Inc. |
Modulators of gsk-3 activity
|
|
CA2601257A1
(en)
|
2005-03-10 |
2006-09-21 |
Bayer Pharmaceuticals Corporation |
Pyrimidine derivatives for treatment of hyperproliferative disorders
|
|
WO2007032445A1
(ja)
|
2005-09-16 |
2007-03-22 |
Kyowa Hakko Kogyo Co., Ltd. |
タンパク質キナーゼ阻害剤
|
|
EP2046759A1
(en)
|
2006-07-21 |
2009-04-15 |
Novartis AG |
2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors
|
|
US8188113B2
(en)
|
2006-09-14 |
2012-05-29 |
Deciphera Pharmaceuticals, Inc. |
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US20080139531A1
(en)
|
2006-12-04 |
2008-06-12 |
Alcon Manufacturing Ltd. |
Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair
|
|
CL2007003693A1
(es)
*
|
2006-12-22 |
2008-06-27 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.
|
|
JP4782239B2
(ja)
|
2007-04-18 |
2011-09-28 |
ファイザー・プロダクツ・インク |
異常細胞増殖治療のためのスルホニルアミド誘導体
|
|
KR20100017441A
(ko)
|
2007-04-27 |
2010-02-16 |
아스트라제네카 아베 |
증식성 병태를 치료하기 위한 ＥｐｈＢ4 키나제 억제제로서의 Ｎ'-(페닐)-Ｎ-(모르폴린-4-일-피리딘-2-일)-피리미딘-2,4-디아민 유도체
|
|
EA201000101A1
(ru)
|
2007-07-16 |
2010-08-30 |
Астразенека Аб |
Производные пиримидина 934
|
|
CA2693594A1
(en)
|
2007-07-17 |
2009-01-22 |
Rigel Pharmaceuticals, Inc. |
Cyclic amine substituted pyrimidinediamines as pkc inhibitors
|
|
JP5269444B2
(ja)
*
|
2008-03-11 |
2013-08-21 |
東ソー・ファインケム株式会社 |
固体ルイス酸触媒、それを用いたディールスアルダー付加物の製造方法
|
|
KR20100132550A
(ko)
|
2008-04-16 |
2010-12-17 |
포톨라 파마슈티컬스, 인코포레이티드 |
ｓｙｋ 또는 ＪＡＫ 키나제 억제제로서의 ２,６－디아미노-피리미딘－５－일－카르복스아미드
|
|
MY155639A
(en)
|
2008-04-16 |
2015-11-13 |
Portola Pharm Inc |
2, 6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinases inhibitors
|
|
US8258144B2
(en)
|
2008-04-22 |
2012-09-04 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
WO2009132980A1
(en)
|
2008-04-29 |
2009-11-05 |
F. Hoffmann-La Roche Ag |
Pyrimidinyl pyridone inhibitors of jnk.
|
|
PT2300013T
(pt)
|
2008-05-21 |
2017-10-31 |
Ariad Pharma Inc |
Derivados de fósforo como inibidores de cinases
|
|
UY31929A
(es)
|
2008-06-25 |
2010-01-05 |
Irm Llc |
Compuestos y composiciones como inhibidores de cinasa
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
EP2361248B1
(en)
|
2008-06-27 |
2018-09-19 |
Celgene CAR LLC |
Heteroaryl compounds and uses thereof
|
|
BRPI0918472A2
(pt)
|
2008-09-01 |
2015-12-01 |
Astellas Pharma Inc |
composto 2,4-diaminopirimidina
|
|
EP2159220A1
(en)
*
|
2008-09-02 |
2010-03-03 |
Nabriva Therapeutics AG |
Organic compounds
|
|
TWI453207B
(zh)
*
|
2008-09-08 |
2014-09-21 |
Signal Pharm Llc |
胺基三唑并吡啶，其組合物及使用其之治療方法
|
|
BRPI0918045A2
(pt)
|
2008-09-18 |
2015-12-01 |
Astellas Pharma Inc |
compostos de carboxamida heterocíclicos
|
|
TW201016676A
(en)
|
2008-10-03 |
2010-05-01 |
Astrazeneca Ab |
Heterocyclic derivatives and methods of use thereof
|
|
MX2011004565A
(es)
|
2008-10-31 |
2011-07-28 |
Centocor Ortho Biotech Inc |
Diferenciacion de celulas madre embrionarias humanas al linaje endocrino pancreatico.
|
|
WO2010068863A2
(en)
|
2008-12-12 |
2010-06-17 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimidine compounds and methods of making and using same
|
|
WO2010080864A1
(en)
|
2009-01-12 |
2010-07-15 |
Array Biopharma Inc. |
Piperidine-containing compounds and use thereof
|
|
CA2749403A1
(en)
|
2009-01-13 |
2010-09-02 |
Glaxo Group Limited |
Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
|
|
ES2635504T3
(es)
|
2009-01-21 |
2017-10-04 |
Rigel Pharmaceuticals, Inc. |
Derivados de N2-(3-piridilo o fenil)-N4-(4-piperidil)-2,4-pirimidinadiamina útiles en el tratamiento de enfermedades inflamatorias, toimmunitarias o proliferativas
|
|
AR076550A1
(es)
|
2009-05-06 |
2011-06-22 |
Portola Pharm Inc |
Inhibidores de la janus tirosina kinasa (jak)
|
|
EP3009428B1
(en)
|
2009-05-08 |
2018-02-21 |
Astellas Pharma Inc. |
Diamino heterocyclic carboxamide compound
|
|
JP2012148977A
(ja)
|
2009-05-20 |
2012-08-09 |
Astellas Pharma Inc |
アミノシクロヘキシルアルキル基を有する２，４−ジアミノピリミジン化合物
|
|
CA2764983A1
(en)
|
2009-06-10 |
2010-12-16 |
Abbott Laboratories |
2- ( lh-pyrazol-4 -ylamino ) -pyrimidine as kinase inhibitors
|
|
JP2012197231A
(ja)
|
2009-08-06 |
2012-10-18 |
Oncotherapy Science Ltd |
Ｔｔｋ阻害作用を有するピリジンおよびピリミジン誘導体
|
|
WO2011065800A2
(ko)
|
2009-11-30 |
2011-06-03 |
주식회사 오스코텍 |
피리미딘 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
|
|
CA2780759A1
(en)
|
2009-12-01 |
2011-06-09 |
Rigel Pharmaceuticals, Inc. |
Protein kinase c inhibitors and uses thereof
|
|
US20130172562A1
(en)
*
|
2010-06-17 |
2013-07-04 |
Dr. Reddy's Laboratories, Inc. |
Process for the preparation of a single enantiomer of 3-aminopiperidine dihydrochloride
|
|
JP6035238B2
(ja)
|
2010-07-21 |
2016-11-30 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
プロテインキナーゼｃ阻害剤およびその使用
|
|
US8580805B2
(en)
|
2010-08-31 |
2013-11-12 |
Hubert Maehr |
Pyrimidine carboxamide derivatives
|
|
US20130244963A1
(en)
|
2010-09-30 |
2013-09-19 |
Portola Pharmaceuticals, Inc. |
Combination therapy with 4-(3-(2h-1,2,3-triazol-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide
|
|
EP2621489A1
(en)
|
2010-09-30 |
2013-08-07 |
Portola Pharmaceuticals, Inc. |
Combinations of 4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide and fludarabine
|
|
PE20140502A1
(es)
|
2011-04-22 |
2014-05-02 |
Signal Pharm Llc |
Pirimidinas sustituidas de diaminocarboxamida y diaminocarbonitrilo, composiciones de las mismas y metodos de tratamiento con las mismas
|
|
WO2014019166A1
(zh)
*
|
2012-08-01 |
2014-02-06 |
上海威智医药科技有限公司 |
高活性硼烷类化合物的工业化生产方法
|
|
JP2014031327A
(ja)
*
|
2012-08-02 |
2014-02-20 |
Kaneka Corp |
光学活性シス−２−アミノ−シクロヘキサンカルボン酸誘導体およびその前駆体の製造法
|
|
TW201609671A
(zh)
|
2013-12-20 |
2016-03-16 |
標誌製藥公司 |
經取代之二胺基嘧啶基化合物、其組合物及使用其之治療方法
|
|
NZ715903A
(en)
|
2014-01-30 |
2017-06-30 |
Signal Pharm Llc |
Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
|
|
TWI523838B
(zh)
*
|
2014-03-21 |
2016-03-01 |
Far Eastern New Century Corp |
Terephthalic acid and 4-methyl-3-cyclohexene-1-carboxylic acid Ester preparation method
|
|
EA201790779A1
(ru)
|
2014-10-06 |
2017-09-29 |
СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Замещенные аминопуриновые соединения, их композиции и способы лечения с использованием таких соединений
|
|
JP6903577B2
(ja)
|
2014-12-16 |
2021-07-14 |
シグナル ファーマシューティカルズ，エルエルシー |
皮膚におけるｃ−Ｊｕｎ Ｎ末端キナーゼの阻害の測定方法
|
|
BR112017012795A2
(pt)
|
2014-12-16 |
2018-01-02 |
Signal Pharmaceuticals, Llc |
Formulações de 2-(terc-butilamino)-4-((1r,3r,4r)-3- hidroxi-4-metilciclo-hexilamino)-pirimidina-5- carboxamida
|
|
CA2975260C
(en)
|
2015-01-29 |
2024-05-21 |
Signal Pharmaceuticals Llc |
Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
|
|
MX2018001004A
(es)
*
|
2015-07-24 |
2018-06-07 |
Celgene Corp |
Metodos de sintesis de clorhidrato de (1r,2r,5r)-5-amino-2-metilci clohexanol e intermedios utiles en este.
|